Drugs Made In America Acquisition Corp. (DMAA)

NASDAQ: DMAA · Real-Time Price · USD
10.56
0.00 (-0.05%)
At close: Apr 28, 2026, 4:00 PM EDT
10.56
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
4.97%
Market Cap 356.05M
Revenue (ttm) n/a
Net Income (ttm) 5.94M
Shares Out 33.72M
EPS (ttm) 0.19
PE Ratio 56.27
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 637
Open 10.57
Previous Close 10.57
Day's Range 10.56 - 10.57
52-Week Range 10.05 - 10.61
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About DMAA

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Jan 28, 2025
Country United States
Stock Exchange NASDAQ
Ticker Symbol DMAA
Full Company Profile

News

There is no news available yet.